MAJI.US Marijuana Inc.

Healthcare Biotechnology USA Stocks
0.0030 USD
Close of Nov 3, 2026
0.0020 0.0800
Market cap
USD 268K
P/E
-
P/B
203.08x
ROE
99.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Apr 2026.

Is MAJI.US undervalued?

Graham number

The Graham number of Marijuana Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Marijuana Inc. fundamental analysis

No fundamental analysis for Marijuana Inc. yet.

Marijuana Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Marijuana Inc.

Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.

Full company profile